Core Viewpoint - Beiding Co., Ltd. has shown a significant increase in stock price this year, with a year-to-date rise of 28.65%, despite recent minor declines in the short term [2]. Group 1: Stock Performance - As of November 27, Beiding's stock price increased by 2.07% to 12.32 CNY per share, with a total market capitalization of 4.021 billion CNY [1]. - The stock has experienced a decline of 0.81% over the last five trading days, 0.65% over the last 20 days, and 6.38% over the last 60 days [2]. - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 43.2418 million CNY on April 25, accounting for 36.49% of total trading volume [2]. Group 2: Financial Performance - For the period from January to September 2025, Beiding achieved a revenue of 651 million CNY, reflecting a year-on-year growth of 28.57% [3]. - The net profit attributable to shareholders reached 82.916 million CNY, marking a significant year-on-year increase of 113.25% [3]. Group 3: Shareholder Information - As of November 20, the number of shareholders increased to 15,500, up by 1.95%, while the average number of circulating shares per person decreased by 1.91% to 20,405 shares [3]. - Since its A-share listing, Beiding has distributed a total of 357 million CNY in dividends, with 204 million CNY distributed over the past three years [4]. - As of September 30, 2025, the top ten circulating shareholders include a new shareholder, Dazheng Zhongzheng 360 Internet + Index A, holding 1.2726 million shares [4].

Core Viewpoint - The stock of Chuan Yi Co., Ltd. has experienced fluctuations, with a recent decline of 2.01% and a year-to-date increase of 21.14%, indicating volatility in the market performance of the company [1]. Financial Performance - For the period from January to September 2025, Chuan Yi Co., Ltd. reported a revenue of 4.89 billion yuan, a year-on-year decrease of 13.02%, and a net profit attributable to shareholders of 462 million yuan, down 17.28% compared to the previous year [2]. - Cumulative cash dividends since the company's A-share listing amount to 1.527 billion yuan, with 828 million yuan distributed over the last three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders for Chuan Yi Co., Ltd. was 18,600, a decrease of 2.54% from the previous period, while the average circulating shares per person increased by 2.60% to 27,482 shares [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 12.0266 million shares, an increase of 8.5233 million shares from the previous period [3]. Market Activity - The stock price of Chuan Yi Co., Ltd. is currently at 25.41 yuan per share, with a market capitalization of 13.04 billion yuan. The trading volume shows a net outflow of 17.8569 million yuan from main funds [1]. - The company operates primarily in the industrial automation sector, with 86.81% of its revenue coming from industrial automation instruments and devices [1].

Core Viewpoint - Tiger Med's stock price has shown a decline of 4.42% year-to-date, with significant drops over various trading periods, indicating potential challenges in the market [1][2]. Financial Performance - For the period from January to September 2025, Tiger Med reported a revenue of 5.026 billion yuan, a year-on-year decrease of 0.82%, while the net profit attributable to shareholders increased by 25.45% to 1.020 billion yuan [2]. - Cumulative cash dividends since the A-share listing amount to 2.458 billion yuan, with 1.154 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 6.01% to 48,400, with an average of 0 shares per shareholder [2]. - The top circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 25.097 million shares, and other notable funds such as China Europe Medical Health Mixed A and Huabao CSI Medical ETF [3]. Market Activity - On November 26, Tiger Med's stock rose by 2.08% to 51.92 yuan per share, with a trading volume of 154 million yuan and a turnover rate of 0.53% [1]. - The stock has experienced a net inflow of 8.478 million yuan from major funds, with significant buying and selling activity noted [1]. Business Overview - Tiger Med, established on December 15, 2004, and listed on August 17, 2012, specializes in providing professional clinical research services for pharmaceutical and health-related products, covering phases I to IV of clinical trials [1]. - The company's revenue composition includes 52.60% from clinical trial-related services and 45.21% from clinical trial technical services [1]. Industry Classification - Tiger Med is classified under the pharmaceutical and biological sector, specifically in medical services and medical research outsourcing [2]. - The company is associated with various concept sectors, including mid-cap, margin financing, social security heavy positions, medical devices, and internet healthcare [2].

Core Viewpoint - Xiamen Bank's stock price has shown a year-to-date increase of 28.83%, with recent fluctuations indicating a slight decline over the past five trading days and twenty days, while experiencing a modest increase over the past sixty days [1] Financial Performance - As of September 30, 2025, Xiamen Bank reported a net profit of 1.939 billion yuan, reflecting a year-on-year growth of 0.25% [3] - The bank's cumulative cash distribution since its A-share listing amounts to 3.536 billion yuan, with 2.402 billion yuan distributed over the past three years [4] Shareholder Information - The number of shareholders as of September 30, 2025, is 40,800, a decrease of 4.19% from the previous period, while the average circulating shares per person increased by 4.37% to 31,448 shares [3] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, holding 65.435 million shares, a decrease of 10.575 million shares from the previous period [4] Market Activity - On November 25, Xiamen Bank's stock rose by 2.02%, reaching 7.06 yuan per share, with a trading volume of 53.6423 million yuan and a turnover rate of 0.29% [1] - The net inflow of main funds was 994,900 yuan, with significant buying activity from large orders [1]

Core Points - The stock price of Wanze Co., Ltd. increased by 2.02% on November 25, reaching 21.25 CNY per share, with a trading volume of 180 million CNY and a market capitalization of 10.822 billion CNY [1] - Year-to-date, Wanze Co., Ltd. has seen a stock price increase of 65.72%, with a recent decline of 0.56% over the last five trading days [2] Financial Performance - For the period from January to September 2025, Wanze Co., Ltd. achieved a revenue of 941 million CNY, representing a year-on-year growth of 21.00%, and a net profit attributable to shareholders of 170 million CNY, reflecting a growth of 22.45% [3] - The company has distributed a total of 645 million CNY in dividends since its A-share listing, with 107 million CNY distributed over the past three years [4] Shareholder Information - As of September 30, 2025, the number of shareholders for Wanze Co., Ltd. was 26,900, a decrease of 0.83% from the previous period, with an average of 18,595 circulating shares per shareholder, an increase of 0.84% [3] - Among the top ten circulating shareholders, Changxin National Defense Military Industry Quantitative Mixed A is the seventh largest shareholder, holding 11.7722 million shares as a new entrant [4]

Core Points - Tianshan Aluminum's stock price increased by 2.01% on November 25, reaching 12.70 CNY per share, with a total market capitalization of 59.079 billion CNY [1] - The company has seen a year-to-date stock price increase of 69.92%, while it experienced a slight decline of 2.31% over the past five trading days [1] Financial Performance - For the period from January to September 2025, Tianshan Aluminum reported a revenue of 22.321 billion CNY, representing a year-on-year growth of 7.34% [2] - The net profit attributable to shareholders for the same period was 3.340 billion CNY, reflecting an increase of 8.31% compared to the previous year [2] Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 23.85% to 37,800, while the average number of circulating shares per person increased by 31.32% to 109,224 shares [2] - Tianshan Aluminum has distributed a total of 7.480 billion CNY in dividends since its A-share listing, with 4.381 billion CNY distributed over the last three years [3] Ownership Structure - As of September 30, 2025, Hong Kong Central Clearing Limited is the seventh largest circulating shareholder, holding 131 million shares, an increase of 18.5447 million shares from the previous period [3]

Core Viewpoint - Yun Aluminum Co., Ltd. has shown significant stock performance with a year-to-date increase of 79.66%, despite a recent decline of 6.29% over the last five trading days [1] Group 1: Stock Performance - As of November 24, Yun Aluminum's stock price reached 23.41 CNY per share, with a market capitalization of 81.185 billion CNY [1] - The trading volume was 8.22 billion CNY, with a turnover rate of 1.03% [1] - The stock has experienced a 2.32% increase over the last 20 days and a 36.82% increase over the last 60 days [1] Group 2: Financial Performance - For the period from January to September 2025, Yun Aluminum reported a revenue of 44.072 billion CNY, representing a year-on-year growth of 12.47% [2] - The net profit attributable to shareholders for the same period was 4.398 billion CNY, reflecting a year-on-year increase of 15.14% [2] Group 3: Shareholder and Dividend Information - Since its A-share listing, Yun Aluminum has distributed a total of 6.069 billion CNY in dividends, with 3.884 billion CNY distributed over the last three years [3] - As of September 30, 2025, the number of shareholders decreased by 8.51% to 79,100, while the average number of circulating shares per person increased by 9.30% to 43,857 shares [2][3] - The third-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 269 million shares, an increase of 72.0936 million shares from the previous period [3]

Core Viewpoint - Hongfa Technology Co., Ltd. has shown a significant increase in stock price this year, with a year-to-date rise of 29.82%, despite a recent decline in the last five trading days [1][2]. Financial Performance - For the period from January to September 2025, Hongfa achieved a revenue of 12.914 billion yuan, representing a year-on-year growth of 18.82%, and a net profit attributable to shareholders of 1.470 billion yuan, up 15.78% year-on-year [2]. Shareholder Information - As of September 30, 2025, the number of shareholders increased to 49,500, a rise of 66.96%, while the average circulating shares per person decreased by 40.11% to 29,476 shares [2]. - The company has distributed a total of 2.987 billion yuan in dividends since its A-share listing, with 1.370 billion yuan distributed in the last three years [3]. Stock Market Activity - On November 24, Hongfa's stock price rose by 2.04% to 29.03 yuan per share, with a trading volume of 354 million yuan and a turnover rate of 0.84%, leading to a total market capitalization of 43.011 billion yuan [1]. - The net outflow of main funds was 7.5195 million yuan, with large orders showing a buy of 51.2397 million yuan and a sell of 57.8643 million yuan [1]. Business Overview - Hongfa specializes in the production and sales of relays, with relay products accounting for 91.22% of its main business revenue, followed by electrical products at 4.63% and other products at 3.81% [1]. - The company is categorized under the power equipment industry, specifically in grid automation equipment, and is involved in sectors such as rural power grids, solar energy, and smart grids [1].

Company Overview - Lier Chemical Co., Ltd. is located at No. 58, Huasheng Road, Chenghua District, Chengdu, Sichuan Province, established on July 26, 2000, and listed on July 8, 2008. The company primarily engages in the research, production, and sales of efficient, low-toxicity, low-residue safe pesticides, including chloropyridine, organophosphorus, sulfonylurea, and substituted urea [1][2]. Financial Performance - For the period from January to September 2025, Lier Chemical achieved operating revenue of 6.709 billion yuan, representing a year-on-year growth of 29.31%. The net profit attributable to the parent company was 381 million yuan, showing a significant increase of 189.07% year-on-year [2]. - The company has cumulatively distributed 1.496 billion yuan in dividends since its A-share listing, with 720 million yuan distributed over the past three years [3]. Stock Performance - As of November 24, Lier Chemical's stock price decreased by 2.07%, trading at 12.78 yuan per share, with a total market capitalization of 10.230 billion yuan. The stock has increased by 62.39% year-to-date, but has seen a decline of 4.77% over the last five trading days [1]. - The stock's trading volume on November 24 was 154 million yuan, with a turnover rate of 1.48%. The net outflow of main funds was 12.1278 million yuan, with large orders showing a buy of 27.7502 million yuan and a sell of 29.6346 million yuan [1]. Shareholder Structure - As of October 31, the number of shareholders for Lier Chemical was 42,000, a decrease of 2.35% from the previous period. The average circulating shares per person increased by 2.40% to 19,008 shares [2]. - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited ranked as the fifth largest with 13.308 million shares, an increase of 5.8814 million shares from the previous period. New shareholder Penghua China 50 Mixed Fund holds 5.256 million shares, while Southern CSI 1000 ETF reduced its holdings by 60,900 shares [3].

Core Viewpoint - Kstar's stock price has experienced fluctuations, with a year-to-date increase of 87.04% but a recent decline of 7.95% over the last five trading days [1] Company Overview - Kstar Technology Co., Ltd. is based in Nanshan District, Shenzhen, Guangdong, and was established on March 17, 1993. It was listed on December 7, 2010. The company specializes in the R&D, production, sales, and services of UPS and valve-regulated sealed lead-acid batteries [1] - The main revenue composition includes smart power and data centers (60.04%), solar storage and charging products and systems (37.16%), supporting products (1.40%), other (0.96%), and new energy revenue (0.44%) [1] Financial Performance - For the period from January to September 2025, Kstar achieved operating revenue of 3.609 billion yuan, representing a year-on-year growth of 23.93%. The net profit attributable to the parent company was 446 million yuan, with a year-on-year increase of 24.93% [2] - Kstar has distributed a total of 1.544 billion yuan in dividends since its A-share listing, with 602 million yuan distributed in the last three years [3] Shareholder Structure - As of September 30, 2025, Kstar had 46,000 shareholders, with an average of 12,285 circulating shares per person. The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 10.6908 million shares, an increase of 2.45 million shares from the previous period [2][3] - New institutional shareholders include Bosera Huixing Return Mixed Fund, holding 5.0283 million shares, and Huatai-PineBridge Technology Innovation Mixed Fund, holding 4.0335 million shares [3]